[1]
|
Jin, J., et al. (2013) Brain Metastases as the First Symptom of Lung Cancer: A Clinical Study from an Asian Medical Center. Journal of Cancer Research and Clinical Oncology, 139, 403-408. https://doi.org/10.1007/s00432-012-1344-6
|
[2]
|
Svokos, K.A., Salhia, B. and Toms, S.A. (2014) Molecular Biol-ogy of Brain Metastasis. International Journal of Molecular Sciences, 15, 9519-9530. https://doi.org/10.3390/ijms15069519
|
[3]
|
Winkler, F. (2015) The Brain Metastatic Niche. Journal of Molecular Medicine (Berlin), 93, 1213-1220.
https://doi.org/10.1007/s00109-015-1357-0
|
[4]
|
Luzzi, K.J., et al. (1998) Multistep Nature of Metastatic Ineffi-ciency: Dormancy of Solitary Cells after Successful Extravasation and Limited Survival of Early Micrometastases. The American Journal of Pathology, 153, 865-873.
https://doi.org/10.1016/S0002-9440(10)65628-3
|
[5]
|
Palmieri, D., et al. (2007) The Biology of Metastasis to a Sanctuary Site. Clinical Cancer Research, 13, 1656-1662.
https://doi.org/10.1158/1078-0432.CCR-06-2659
|
[6]
|
Deeken, J.F. and Löscher, W. (2007) The Blood-Brain Bar-rier and Cancer: Transporters, Treatment, and Trojan Horses. Clinical Cancer Research, 13, 1663-1674. https://doi.org/10.1158/1078-0432.CCR-06-2854
|
[7]
|
Abbott, N.J., Rönnbäck, L. and Hansson, E. (2006) Astro-cyte-Endothelial Interactions at the Blood-Brain Barrier. Nature Reviews Neuroscience, 7, 41-53. https://doi.org/10.1038/nrn1824
|
[8]
|
Preusser, M., et al. (2012) Brain Metastases: Pathobiology and Emerging Targeted Therapies. Acta Neuropathologica, 123, 205-222. https://doi.org/10.1007/s00401-011-0933-9
|
[9]
|
Eichler, A.F., et al. (2011) The Biology of Brain Metastases-Translation to New Therapies. Nature Reviews Clinical Oncology, 8, 344-356. https://doi.org/10.1038/nrclinonc.2011.58
|
[10]
|
Grinberg-Rashi, H., et al. (2009) The Expression of Three Genes in Primary Non-Small Cell Lung Cancer Is Associated with Metastatic Spread to the Brain. Clinical Cancer Re-search, 15, 1755-1761.
https://doi.org/10.1158/1078-0432.CCR-08-2124
|
[11]
|
Yoo, J., et al. (2012) Immunohistochemical Expression of DCUN1D1 in Non-Small Cell Lung Carcinoma: Its Relation to Brain Metastasis. Cancer Research and Treatment, 44, 57-62. https://doi.org/10.4143/crt.2012.44.1.57
|
[12]
|
Wang, H., et al. (2019) Genes Associated with Increased Brain Metastasis Risk in Non-Small Cell Lung Cancer: Comprehensive Genomic Profiling of 61 Resected Brain Metas-tases versus Primary Non-Small Cell Lung Cancer (Guangdong Association Study of Thoracic Oncology 1036). Cancer, 125, 3535-3544. https://doi.org/10.1002/cncr.32372
|
[13]
|
Desgrosellier, J.S. and Cheresh, D.A. (2010) Integrins in Cancer: Biological Implications and Therapeutic Opportunities. Nature Reviews Cancer, 10, 9-22. https://doi.org/10.1038/nrc2748
|
[14]
|
Yoshimasu, T., et al. (2004) Increased Expression of Integrin α3β1 in Highly Brain Metastatic Subclone of a Human Non-Small Cell Lung Cancer Cell Line. Cancer Science, 95, 142-148.
https://doi.org/10.1111/j.1349-7006.2004.tb03195.x
|
[15]
|
Sipos, E., et al. (2012) Proinflammatory Adhesion Mol-ecules Facilitate Polychlorinated Biphenyl-Mediated Enhancement of Brain Metastasis Formation. Toxicological Sciences, 126, 362-371. https://doi.org/10.1093/toxsci/kfr349
|
[16]
|
Münsterberg, J., et al. (2020) ALCAM Contributes to Brain Metastasis Formation in Non-Small-Cell Lung Cancer through Interaction with the Vascular Endothelium. Neu-ro-Oncology, 22, 955-966.
https://doi.org/10.1093/neuonc/noaa028
|
[17]
|
Jiang, W.G. (1996) E-cadherin and Its Associated Protein Catenins, Cancer Invasion and Metastasis. British Journal of Surgery, 83, 437-446. https://doi.org/10.1002/bjs.1800830404
|
[18]
|
Kreiseder, B., et al. (2013) α-Catulin Downregulates E-cadherin and Promotes Melanoma Progression and Invasion. International Journal of Cancer, 132, 521-530. https://doi.org/10.1002/ijc.27698
|
[19]
|
Yoo, J.Y., et al. (2012) E-cadherin as a Predictive Marker of Brain Metasta-sis in Non-Small-Cell Lung Cancer, and Its Regulation by Pioglitazone in a Preclinical Model. Journal of Neu-ro-Oncology, 109, 219-227.
https://doi.org/10.1007/s11060-012-0890-8
|
[20]
|
London, N.R., Whitehead, K.J. and Li, D.Y. (2009) Endogenous Endothelial Cell Signaling Systems Maintain Vascular Stability. Angiogenesis, 12, 149-158. https://doi.org/10.1007/s10456-009-9130-z
|
[21]
|
Yano, S., et al. (2000) Expression of Vascular Endothelial Growth Factor Is Necessary but Not Sufficient for Production and Growth of Brain Metastasis. Cancer Research, 60, 4959-4967.
|
[22]
|
Jubb, A.M., et al. (2011) Vascular Phenotypes in Primary Non-Small Cell Lung Carcinomas and Matched Brain Metastases. British Journal of Cancer, 104, 1877-1881. https://doi.org/10.1038/bjc.2011.147
|
[23]
|
Keeley, E.C., Mehrad, B. and Strieter, R.M. (2010) CXC Chemokines in Cancer Angiogenesis and Metastases. Advances in Cancer Research, 106, 91-111. https://doi.org/10.1016/S0065-230X(10)06003-3
|
[24]
|
Fokas, E., Steinbach, J.P. and Rödel, C. (2013) Biology of Brain Metastases and Novel Targeted Therapies: Time to Translate the Research. Biochimica et Biophysica Acta, 1835, 61-75. https://doi.org/10.1016/j.bbcan.2012.10.005
|
[25]
|
Paratore, S., et al. (2011) CXCR4 and CXCL12 Immuno-reactivities Differentiate Primary Non-Small-Cell Lung Cancer with or without Brain Metastases. Cancer Biomarkers, 10, 79-89. https://doi.org/10.3233/CBM-2011-0232
|
[26]
|
Rizzo, A., et al. (2015) Melanoma Cells Homing to the Brain: An in Vitro Model. BioMed Research International, 2015, Article ID: 476069. https://doi.org/10.1155/2015/476069
|
[27]
|
Liu, H., et al. (2012) The Role of MMP-1 in Breast Cancer Growth and Metastasis to the Brain in a Xenograft Model. BMC Cancer, 12, Article No. 583. https://doi.org/10.1186/1471-2407-12-583
|
[28]
|
Hu, L., et al. (2010) Biological Characteristics of a Specific Brain Metastatic Cell Line Derived from Human Lung Adenocarcinoma. Medical Oncology, 27, 708-714. https://doi.org/10.1007/s12032-009-9273-1
|
[29]
|
Shintani, Y., et al. (2004) Overexpression of ADAM9 in Non-Small Cell Lung Cancer Correlates with Brain Metastasis. Cancer Research, 64, 4190-4196. https://doi.org/10.1158/0008-5472.CAN-03-3235
|
[30]
|
Chen, L.T., et al. (2012) MicroRNA-378 Is Associated with Non-Small Cell Lung Cancer Brain Metastasis by Promoting Cell Migration, Invasion and Tumor Angiogenesis. Medical Oncology, 29, 1673-1680.
https://doi.org/10.1007/s12032-011-0083-x
|
[31]
|
Arora, S., et al. (2011) MicroRNA-328 Is Associated with (Non-Small) Cell Lung Cancer (NSCLC) Brain Metastasis and Mediates NSCLC Migration. International Journal of Cancer, 129, 2621-2631. https://doi.org/10.1002/ijc.25939
|
[32]
|
Wei, C., et al. (2019) MicroRNA-330-3p Pro-motes Brain Metastasis and Epithelial-Mesenchymal Transition via GRIA3 in Non-Small Cell Lung Cancer. Aging (Al-bany NY), 11, 6734-6761. https://doi.org/10.18632/aging.102201
|
[33]
|
Wang, H., et al. (2019) N6-Methyladenosine Induced miR-143-3p Promotes the Brain Metastasis of Lung Cancer via Regulation of VASH1. Molecular Cancer, 18, 181. https://doi.org/10.1186/s12943-019-1108-x
|
[34]
|
Mok, T.S., et al. (2009) Gefitinib or Carboplatin-Paclitaxel in Pulmonary Adenocarcinoma. The New England Journal of Medicine, 361, 947-957. https://doi.org/10.1056/NEJMoa0810699
|
[35]
|
Ouyang, W., et al. (2020) Risk Factors of Metachronous Brain Me-tastasis in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer. BMC Cancer, 20, Article No. 699. https://doi.org/10.1186/s12885-020-07202-8
|
[36]
|
Burel-Vandenbos, F., et al. (2013) EGFR Mutation Status in Brain Metastases of Non-Small Cell Lung Carcinoma. Journal of Neuro-Oncology, 111, 1-10. https://doi.org/10.1007/s11060-012-0990-5
|
[37]
|
Hsu, F., et al. (2016) EGFR Mutation Status on Brain Metastases from Non-Small Cell Lung Cancer. Lung Cancer, 96, 101-107. https://doi.org/10.1016/j.lungcan.2016.04.004
|
[38]
|
Bhatt, V.R., et al. (2017) Epidermal Growth Factor Receptor Mutational Status and Brain Metastases in Non-Small-Cell Lung Cancer. Journal of Global Oncology, 3, 208-217. https://doi.org/10.1200/JGO.2016.003392
|
[39]
|
Rangachari, D., et al. (2015) Brain Metastases in Patients with EGFR-Mutated or ALK-Rearranged Non-Small-Cell Lung Cancers. Lung Cancer, 88, 108-111. https://doi.org/10.1016/j.lungcan.2015.01.020
|
[40]
|
Gainor, J.F., et al. (2013) The Central Nervous System as a Sanctuary Site in ALK-Positive Non-Small-Cell Lung Cancer. Journal of Thoracic Oncology, 8, 1570-1573. https://doi.org/10.1097/JTO.0000000000000029
|
[41]
|
Okamoto, H., et al. (1993) Intradural Parenchymal Involve-ment in the Spinal Subarachnoid Space Associated with Primary Lung Cancer. Cancer, 72, 2583-2588.
https://doi.org/10.1002/1097-0142(19931101)72:9<2583::AID-CNCR2820720912>3.0.CO;2-K
|
[42]
|
Grossman, S.A. and Krabak, M.J. (1999) Leptomeningeal Carcinomatosis. Cancer Treatment Reviews, 25, 103-119.
https://doi.org/10.1053/ctrv.1999.0119
|